×

Altru Cancer Center seeks patients for clinical trial

By Jim Johnson Apr 24, 2024 | 4:27 PM

(KNOX) – Altru Cancer Center is seeking patients for a clinical trial for CurativeStage Non-Small Cell Lung Cancer (NSCLC).
The clinical trial is investigating whether a combination of drugs and experimental vaccine therapy could stop NSCLC from recurring, after a patient has surgery to remove the cancer, or from spreading to other parts of their body.
NSCLCs are the most common type of lung cancer with nearly 8 in 10 cases falling into this category.
Patients seeking to be part of the clinical trial must meet the criteria and be referred by their oncologist.

FOLLOW US FOR INSTANT UPDATES!